1.Medical cannabis in dermatology: A position paper from the Philippine Dermatological Society
Bryan Guevara, MD, FPDS,FDSP ; Hester Gail Lim, MD, FPDS ; Josef Symon S. Concha, MD, DPDS ; Zharlah Gulmatico-Flores, MD, MMPHA, FPDS ; Camille B. Angeles, MD,FPDS
Journal of the Philippine Dermatological Society 2023;32(1):3-6
2.Stem cell therapy in dermatology: A position paper from the Philippine Dermatological Society
Bryan Guevara, MD, FPDS,FDSP ; Hester Gail Lim, MD, FPDS ; Josef Symon S. Concha, MD, DPDS ; Zharlah Gulmatico-Flores, MD, MMPHA, FPDS ; Camille B. Angeles, MD,FPDS
Journal of the Philippine Dermatological Society 2023;32(1):7-12
3.A literature review and clinical consensus guidelines on the management of Bullous Pemphigoid
Clarisse G. Mendoza ; Josef Symon S. Concha ; Cybill Dianne C. Uy ; Bryan K. Guevara ; Evelyn R. Gonzaga ; Maria Jasmin J. Jamora ; Jamaine L. Cruz‑Regalado ; Katrina C. Estrella ; Melanie Joy D. Ruiz ; Rogelio A. Balagat ; Mae N. Ramirez‑Quizon ; Johanna Pauline L. Dizon ; Marie Eleanore O. Nicolas
Journal of the Philippine Dermatological Society 2023;32(2):63-76
Bullous pemphigoid (BP) is the most common autoimmune blistering disease primarily characterized by
tense blisters and occasionally with urticarial plaques, affecting the skin and mucous membranes. These are
caused by autoantibodies against BP180 and BP230 which target antigens on the basement membrane zone.
The diagnosis relies on the integration of clinical, histopathological, immunopathological, and serological
findings. The management depends on the clinical extent and severity. We present in this article a literature
review and the clinical consensus guidelines of the Immunodermatology Subspecialty Core Group of the
Philippine Dermatological Society in the management of BP.
Pemphigoid, Bullous